Novel Mutations in the Gene Encoding Secreted Lymphocyte Antigen-6/Urokinase-type Plasminogen Activator Receptor-related Protein-1 (SLURP-1) and Description of Five Ancestral Haplotypes in Patients with Mal de Meleda  by Marrakchi, Slaheddine et al.
ORIGINAL ARTICLE
See related Commentary on page v
Novel Mutations in the Gene Encoding Secreted Lymphocyte
Antigen-6/Urokinase-type Plasminogen Activator Receptor-
related Protein-1 (SLURP-1) and Description of Five Ancestral
Haplotypes in Patients with Mal de Meleda
Slaheddine Marrakchi, SteŁ phanie Audebert,
n Bakar Bouadjar,w Christina Has,n Caroline Lefe' vre,n
Colin Munro,z Susan Cure,y Florence Jobard,n Susanne Morlot,z Daniel Hohl,nn Jean-Franc, ois Prud’homme,ww
Abdelmadjid Zahaf, Hamida Turki, and Judith Fischern
CHU Heidi Chaker, Department of Dermatology, Sfax,Tunisia; nCentre National de GeŁ notypage, Evry, France; wCHU Bab-El-Oued, Department of
Dermatology, Algiers, Algeria; zSouth Glasgow University Hospitals NHS Trust, Department of Dermatology, Scotland, U.K.; yGenoscope, Evry, France;
zPraxis fˇr Humangenetik, Hannover, Germany; nnCHUV Lausanne, Department of Dermatology, Lausanne, Switzerland; wwGeŁ neŁ thon, Evry, France
Mal de Meleda is a recessive, transgressive palmoplantar
keratoderma for which we previously identi¢ed muta-
tions in the gene encoding secreted lymphocyte anti-
gen-6/urokinase-type plasminogen activator receptor-
related protein-1 (SLURP-1). In this report we describe
two new mutations: (i) a founder mutation, which
changes a conserved cysteine residue to tyrosine
(C99Y) in a large inbred Tunisian pedigree, and (ii)
a signal sequence mutation (W15R), which was homo-
zygous in a German family and heterozygous in a
Scottish patient. Four ancestral haplotypes were ob-
served in 69 patients from countries around the Medi-
terranean basin, and an additional haplotype was
found in the German and Scottish patients. Key words:
palmoplantar keratoderma/Mal de Meleda/ARS (com-
ponent B) mutations/secreted lymphocyte antigen-
6/urokinase-type plasminogen activator receptor related
protein-1/ancestral haplotypes / SLURP-1. J Invest
Dermatol 120:351 ^355, 2003
M
al de Meleda (MdM, MIM 248300) is a trans-
gressive palmoplantar keratoderma associated
with perioral erythema, hyperhidrosis, brachy-
dactyly, nail abnormalities, and lichenoid
plaques. The progressive character of the lesions
can lead to severe functional handicap with reduced mobility
of hands and feet. We previously reported the identi¢cation of
mutations in the ARS (component B) gene, which encodes a
secreted Ly6/uPAR (lymphocyte antigen 6/urokinase-type
plasminogen activator receptor) related protein-1 (SLURP-1;
Fischer et al, 2001). This protein is a non-glycosyl phosphatidyl
inositol-anchored member of the Ly6/uPAR superfamily, in
which most members have been localized in a cluster on chromo-
some 8q24.3. This receptor (uPAR) is known to interact with
integrin (Simon et al, 2000). The amino acid composition of
SLURP-1 is closely related to that of cytotoxins, such as snake
venom a-neurotoxins and cardiotoxins (Ploug and Ellis, 1994).
SLURP-1 may function as a ligand for a receptor yet to be iden-
ti¢ed and may interfere with weak intercellular adhesion as
has been shown for the mouse Ly6d and its ligand Ly6d-L
(Apostolopoulos et al, 2000).
We studied 11 nuclear families from the Sfax region in Tunisia
comprising 22 patients and 60 nona¡ected family members
(Fig 1), four Algerian families, including six patients and 14 non-
a¡ected family members, one German family originally from the
Sudetenland, including one patient, his parents and a sister, and
an isolated case from Scotland, whose ancestors were farmers
from Ayrshire for several generations.With the exception of the
Scottish patient whose parents were unrelated, all the families are
consanguineous.
The clinical data and pedigree information were recorded by
¢ve dermatologists (B.B., C.M., S.Ma., S.Mo., H.T.). Tunisian pa-
tients presented similar progressive clinical features. Onset in early
infancy was characterized by erythema of the palms and soles, ra-
pidly followed by a di¡use yellowish hyperkeratosis. Keratoderma
of the dorsal surface of the distal phalanges progressively extended
to the dorsa of the hands and feet, involving the wrists and the
ankles in the majority of cases. In most patients, the transgressive
keratoderma included the elbows, knees, and ulnar side of the fore-
arms. Yellow keratoderma of the palms and soles was usually out-
lined by a red scaly border. Hyperconvexity of the nails and
conical distal phalanges were constant features of the disease,
mainly in the adult patients. In elderly patients, contractures of
the hands and ¢ngers and sclerodactyly were common features.
Hyperhydrosis, pseudo-ainhum, and brachydactyly were seen in
some patients. The German, Scottish, and Algerian patients also
presented typical symptoms of Mal de Meleda, as described pre-
viously (Bouadjar et al, 2000). Photographs of the hands in ¢ve pa-
tients with typical MdM are shown in Fig 2.
Blood samples were collected from each participant family
member after obtaining written informed consent. DNA
Reprint requests to: Dr Judith Fischer, Centre National de GeŁ notypage,
2 rue Gaston CreŁ mieux, CP 5721, 91057 Evry Cedex, France. Email:
¢scher@cng.fr
Abbreviations: SLURP-1, secreted lymphocyte antigen-6/urokinase-
type plasminogen activator receptor related protein-1; MdM, Mal de
Meleda; GH1, growth hormone 1.
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extraction from peripheral blood leukocytes was performed using
standard procedures. Genotyping with 11 £uorescent markers was
carried out in patients and nona¡ected family members as de-
scribed previously (Fischer et al, 2001). Linkage programs and
parameters were also as previously described. Genotyping results
showed linkage to 8q24, con¢rming genetic homogeneity of Mal
de Meleda in the families we studied. The maximum pairwise
LOD score for all families was 10.37 for the markerAFMa082wh9
(D8S1836) at y¼ 0.00, without incorporation of consanguineous
loops unless patients were able to supply this information.
The central parts of the haplotypes of the patients in this study
as well as those from a previous study (Fischer et al, 2001) are pre-
sented in Table I. Twenty-one of the 22 Tunisian patients pre-
sented the same homozygous haplotype (D) for nine of the 11
markers studied con¢rming the existence of consanguinity and
a founder e¡ect in this kindred, which included 10 nuclear
Figure 2. Typical aspect of palms and dorsal surfaces of the hands in ¢ve adult patients with Mal de Meleda. (A) The Algerian patient with a
178+1g4a splice site mutation shows yellow hyperkeratosis of palms, limited by an erythrodermic scaly border and whitish conical, sclerodermiform
phalanges. Lesions are spread over dorsal surfaces in a glove-like distribution; thickening and clubbing of the nails with onycholysis (¢fth ¢nger) and
conical phalanges. (B) Transgressive yellow hyperkeratosis of palms with red desquamative border in a German patient with the 43T-C mutation
(W15R). (C) Three patients from the large Tunisian kindred with the 296G-A mutation (C99Y).Top: Brachydactyly, conical phalanges and pseudo-ain-
hum of the ¢fth ¢nger in a female patient. Fingernails have been colored by the patient. Middle:Typical transgressive character of the lesions spread over the
dorsal surfaces of the hand in the second patient. Bottom: Severe hyperkeratosis and contractures of the hands and the ¢ngers in an elderly patient.
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families. Common ancestors were later con¢rmed by re-inter-
viewing the nuclear families whose members lived near the
coastal town of Sfax.The haplotypes of the fourAlgerian families
(A and B) and the other Tunisian family (A) were identical to
ancestral haplotypes previously observed in families from Algeria
and Croatia (Table I). The German patient was homozygous for a
di¡erent haplotype (E), which was present in a heterozygous state
in the Scottish patient. The other haplotype in the Scottish
patient was the same as ancestral haplotype A. Haplotypes in the
latter had to be deduced, because parental DNAwas not available.
Sequencing of both strands of the three exons and exon/intron
boundaries of the ARS (component B) gene was performed in all
17 families (including the isolated case from Scotland) for all
a¡ected patients and both parents, and in supplementary
non-a¡ected siblings in cases of missing parents. Intronic oligo-
nucleotide primers were de¢ned for exon 1 (forward: 50 -
TACCACGTTCCTGACTCACA-30; reverse: 50 -CTAAGGAGG-
CTCTCAGCCA-30), exon 2 (forward: 50 -CCTTGAAAGATGT-
CAGCGAG-30; reverse: 50 -GTGTGGCAGCCTGTTCTG-30) and
exon 3 (forward: 50 -AGTGAGGGTTCTGACACTGG-30; re-
verse: 50 -CCAGGAAGGACAAAAGTCAT-50). Polymerase chain
reaction (PCR) conditions were as previously described (Fischer
et al, 2001).
Mutation analysis revealed a new homozygous mutation in the
patients from the large Tunisian kindred, 296 G-A, resulting in
a change from cysteine to tyrosine at amino acid position 99
(C99Y) (Fig 1). This mutation disrupts a disul¢de bridge that is
highly conserved in the Ly-6/uPAR superfamily (Adermann et al,
1999). Three Algerian families shared a homozygous splice site
mutation (178þ1g-a), which leads to aberrant splicing. The
eleventhTunisian family and one Algerian family had a homozy-
gous deletion (82delT), leading to a frameshift and creation of a
premature stop codon at amino acid position 32. These latter two
mutations have been reported previously (Fischer et al, 2001). The
German and Scottish patients presented a new missense mutation
(43 T-C), which changes tryptophan to arginine (W15R) in the
signal sequence of the protein (Fig 1C). For the Scottish patient,
the novel heterozygous mutation 43T-C in exon 1 was con-
¢rmed by digesting the PCR product of exon 1with the restric-
tion enzyme NciI (Sigma-Aldrich, Saint Quentin, Fallavier,
France) according to the manufacturer’s instructions (Fig 1C).
This mutation was homozygous in the German patient, but the
Scottish patient was a compound heterozygote in which the sec-
ond mutation was the previously reported deletion (82delT). The
most likely cleavage site for the peptide signal sequence is either
between amino acids 18 and 19 or between 23 and 24 depending
on the prediction program used (PSORT,TargetP, ExPASy; Niel-
sen et al, 1997). TheW15R mutation in which a hydrophobic ami-
no acid is replaced by a hydrophilic one corresponds to the
border of the core hydrophobic region, which is known to be
important for secretion (Izard and Kendall, 1994; Izard et al,
1996). A total of 50 una¡ected individuals (100 chromosomes)
from North Africa and Europe were analyzed for the presence
of the two novel mutations; no sequence variations were found
at these positions. Mutations in peptide signal sequences have al-
ready been reported in autosomal dominant disorders (Repaske
et al, 1997; Siggaard et al, 1999) and as homozygous mutations
in autosomal recessive diseases (Seppen et al, 1996; Sunthornthep-
varakul et al, 1999; Fujita et al, 2000), but it is unusual to ¢nd one
mutation in a signal sequence and another in the secreted part of
Table II. Mutations in the gene encoding SLURP-1 in Mal de Meleda
Mutation Location E¡ect Patient origin Reference
1A-C Exon1 No translation United Arab Eckl et al (2001)2
Initiation codon Emirates
43T-C Exon 1 W15R Germany, This report
Scotland
82delT Exon 2 Frameshift-stop Algeria, Croatia, Fischer et al (2001)
codon at aa 32, Scotland,Tunisia and this study
truncated protein
178 þ 1 g-a Intron 2 Aberrant splicing Algeria Fischer et al (2001)
and this study
256G-A Exon 3 G86R Palestine Eckl et al (2001)2
286C-T Exon 3 R96X-truncated Croatia Fischer et al (2001)
protein
296G-A Exon 3 C99Y Tunisia This report
Table I. Five disease-associated haplotypes in 71 patients with Mal de Meleda
Haplotype A B C D E
CNG003n 126 136 138 140 134
D8S1751n 155 149 149 149 149
D8S1836n 139 147 145 147 153
Exon1 (^60)nn C C C G C
Exon1 (^55)nn C G G G G
Mutation 82delT 178þ1g4a 286C4T 296G4A 43T4C
Origin Algeria/Croatia/Tunisia/Scotland Algeria Croatia Tunisia Germany/Scotland
No. of patients 32 (þ1) 12 4 21 1 (þ1)
No. of kindreds 15 6 3 1 2
The disease-associated haplotypes (A, B, C, D, and E) are contructed from the results of genotyping with microsatellite markersn (CNG003, D8S1751, D8S1836) and SNPsnn (single
nucleotide polymorphisms) at the indicated positions 60 and 55 nucleotides upstream of the initiation codon of exon 1; the numbers represent the allele sizes of the amplimers in base pairs. The
Scottish patient, who was a compound heterozygote and therefore exhibited two di¡erent haplotypes (A, E), was counted twice (in parentheses). Patients and kindreds
include data from Fischer et al (2001).
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the protein in a recessive disorder. Duquesnoy et al (1990)1
described two siblings with growth hormone de¢ciency (IGHD
IA, MIM 262400) who were found to be compound heterozy-
gotes for a 6.7 kb deletion in the GH1 gene and a frameshift mu-
tation in the signal peptide coding region, which prevented
synthesis of GH1.
Combining results from a previous study with those reported
here, we found mutations in the ARS (component B) gene in all
71 patients from 27 families with a con¢rmed diagnosis of MdM.
There was very little phenotypic heterogeneity; with few excep-
tions all ¢ve mutations led to a similar clinical panorama when
age di¡erences were taken into consideration.The question of ge-
netic heterogeneity remains unresolved, however; Eckl et al
(2001)2 and Lestringant et al (2001) have described families with
MdM in which linkage to 8qter could not be demonstrated, and
Van Steensel et al, 2002) reported a MdM patient in which no
mutation in the ARS (component B) gene could be found.
Together with the three mutations already reported, and two
other mutations that were described in an abstract,2 this brings
the total number of mutations reported in MdM to seven (Table
II). Three of these are missense mutations (W15R, G86R, and
C99Y), two lead to premature stop codons (82delT, which creates
a stop codon at amino acid 32, and 286 C-T, which changes
codon 96, which normally encodes arginine to a stop codon
[R96X]); one a¡ects a splice site (178þ1g-a) and one changes
A to C in the initiation codon of exon 1. Two of the missense
mutations involve changing nonpolar to basic amino acids
(W15R and G86R) and one (C99Y) disrupts a conserved disul-
¢de bridge.
We also found two additional sequence variations, 55
(C-G) and 60 (C-G) nucleotides upstream of the ATG
start codon in exon 1 (Table I). These neutral polymorphisms
were not disease-associated, as they were present in both
healthy and a¡ected individuals; however in all ¢ve ancestral
haplotypes, there is a complete association between the alleles
of the three central microsatellite markers, the single
nucleotide polymorphisms and the corresponding mutation.
For instance, all patients with the homozygous 82delT
mutation from the 13 previously reported and 2 newly
analyzed families were homozygous for C at both of these
polymorphic sites, despite their diverse geographic origins
(Algeria, Tunisia, Croatia, including Meleda island, Scotland).
This might represent a founder e¡ect originating in Serbo-
Croatia and spread by Serbo-Croatian sailors at the time of
the Dubrovnik league (fourteenth to seventeenth centuries),
when these seamen transported cargo throughout the
Mediterranean and beyond under the patronage of the
Turkish Empire (Goodwin, 1999; Bakija-Konsuo et al, 2002).
We wish to thank the members of the families for their participation in this study.We
would like to acknowledge the continuous technical support of the GeŁ neŁ thon DNA
bank and its team.This study was supported by the Center National de GeŁ notypage
(CNG), Association Franc6 aise contre les Myopathies (AFM) and GeŁ neŁ thon.
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